Viewing Study NCT01707966


Ignite Creation Date: 2025-12-24 @ 4:41 PM
Ignite Modification Date: 2025-12-27 @ 4:41 AM
Study NCT ID: NCT01707966
Status: COMPLETED
Last Update Posted: 2019-05-15
First Post: 2012-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy
Sponsor: Swiss Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adenocarcinoma of the prostate View
None metastatic castration-resistant prostate cancer View
None maintenance therapy View
None orteronel View
None TAK-700 View